Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis

International Urology and Nephrology

Volumn 28, Issue 2, 1996, Pages 255-261

  Alwakeel, J ^a   Gader, A M A ^a   Hurieb, S ^a   Al Momen, A K ^a   Mitwalli, A ^a   Abu Aisha, H ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; PROTEIN C; PROTEIN S;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEMODIALYSIS; HUMAN; MALE; PERITONEAL DIALYSIS;

EID: 0029980218     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02550871     Document Type: Article

References (25)

1. Remuzzi, G.: Bleeding in renal failure. Lancet, 1205 (1988).
2. Remuzzi, G., Pusinei, F.: Coagulation defects in uremia. Kidney Int., 33 (Suppl. 24), S-13-17.
3. Remuzzi, G., Livio, M., Marchiaro, G., Mecca, G., Gaetamo, G. de: Bleeding in renal failure: Altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron. 222, 347(1978).
4. Nenci, G. G., Barrettini, M., Agnelli, G., Parise, P., Bouncristiani, U., Ballatori, E.: Effect of peritoneal dialysis, haemodialysis and kidney transplantation on blood platelet function. Nephron. 23, 287(1979).
5. Huraib, S., Al-Momen, A. K., Gader, A. M. A., Mitwalli, A., Sulimani, F., Abu Aisha, H.: Effect of recombinant human erythropoietin (rlluEpo) on the hernostatic system in chronic hemodialysis patients. Clin. Nephrol., 36. 252 (1991).
6. van Geet, C., Hauglustaine, D., Verresen, L., Vanrusselt, M., Vermylen, J.: Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients. Thromb. Haemostas., 61, 117(1989).
7. Mannucci, P. M., Owen, W. G.: Basic and clinical aspects of proteins C and S. In: Bloom, A. L., Thomas, D. P. (eds): Haemostasis and Thrombosis. Churchill Livingstone, London 1987, pp. 452-464.
8. Vaziri, N. D., Shah, G. M., Winer, R. L., Gonzales, E., Patel, B., Alikhani, S., Nguyen, Q. X., Yamamoto, J.: Coagulation cascade, fibrinolytic system, antithrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis. Thromb. Res., 53. 173 (1989).
9. Woo, K. T., Wei, S. S., Lee, E. J. C., Lau, Y. K., Lim, C. H.: Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets. Nephron, 40, 25 (1985).
10. Mon, R., Triolo, L., De Stefano, V., Giusti, B. P., De Sole, P., Leone, G.: Plasma levels and loss of antithrombin III in chronic ambulatory peritoneal dialysis and nephrotic patients. Nephron. 48.213 (1988).
11. De Stefano, V., Triolo, L., De Martini, D., Ferrelli, R., Mori, R., Leone, G.: Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome. J. Lab. Clin. Med., 109, 550 (1987).
12. Jones, C. L., Andrew, M., Eddy, A., O'Neil, M., Shalom, N. L, Balfe, J. W.: Coagulation abnormalities in chronic peritoneal dialysis. Pediatr. Nephrol., 4, 152 (1990).
13. Lai, K. N., Yin, J. A., Yuen, P. M. P., Li, P. K. T.: Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis. Nephron. 56. 271 (1990).
14. Alegre, A., Vicente, V., Gonzalez, R., Alberca, L: Effect of hemodialysis on protein C levels. Nephron. 46. 386 (1987).
15. Sorensen, P. J., Knudsen, F., Nielsen, A. H., Dyerberg, J.: Protein C assays in uremia. Thromb. Res., 54. 301 (1989).
16. Bertoli, M., Gasparotto, M. L., Vertoli, U., Ruffati, A., Di Landro, D., Romagnoli, G. F.: Does hypercoagulability exist in CAPD patients? Petit. Dial. Bull.. 4. 237 (1984).
17. Shrader, J., Shrader, F.: Blood coagulation studies in CAPD and treatment with low molecular weight heparin intraperitoneally (Abstract). Peril. Dial. Bull., 6, S19 (1986).
18. Nakamura, Y., Chida, Y., Tomura, S.: Enhanced coagulation fibrinolysis in patients on regular hemodialysis treatment. Nephron, 58, 201 (1991).
19. Toulon, P., Jacquot, C., Capron, L., Frydman, M. O., Vignon, D., Aiach, M.: Anlithrombin HI and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis. Thromb. Haemostas., 57, 263 (1987).
20. Ellis, B. C., Stransky, A. A.: A quick and accurate method for the determination of fibrinogen in plasma. J. Lab. Clin. Med., 58, 477 ( 1961 ).
21. Abildgaard, U., Lie, M., Odegard, O. R.: Antithrombin (heparin co-factor) assay with new chromogenic substrate (S-2238 and chromozym "TH"). Thromb. Res.. 11, 549 (1977).
22. Dulaney, J. T., Hatch, F. E.: Peritoneal dialysis and loss of protein: A review. Kidney Int.. 26. 253 (1984).
23. Kant, K. S., Glueck, H. I., Coots, M. C., Tonne, V. A., Brubaker, R., Penn, I.: Protein S deficiency and skin necrosis associated with continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis.. 19. 264 (1992).
24. Marciniak, E., Gockerman, J. P.: Heparin-induced decrease in circulating antithrombin-III. Lancet, ii. 581 (1977).
25. Gader, A. M. A., Anderton, J. L., Cash, J. D.: The fibrinolytic response to venous occlusion in hypoproteinaemic patients. Thromb. Res., 3, 219 (1973).